Understanding the role of specific proteins in a severe neurological disorder
Official title: Structural and Functional Characterization of Pontocerebellar Hypoplasia Associated Nucleases
Funded at University of Chicago · NIH-11231320 · Data updated 2026-11-12
This study is looking at how changes in certain proteins that help process RNA might cause pontocerebellar hypoplasia (PCH), a serious brain condition, to help find new ways to treat people with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | December 12, 2022 |
| Project end | November 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $37,367 |
| NIH project number | 3R00GM143534-04S1 |
| Project ID | NIH-11231320 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pontocerebellar hypoplasia or those with genetic mutations linked to this condition.
✕Less likely to help
Patients with neurological disorders unrelated to RNA processing or those without genetic mutations associated with pontocerebellar hypoplasia may not benefit from this research.
What this research studies
This research investigates how mutations in certain proteins involved in RNA processing contribute to pontocerebellar hypoplasia (PCH), a serious neurological condition. By examining the assembly and function of the tRNA Splicing Endonuclease (TSEN) complex and other related proteins, the study aims to uncover the mechanisms that lead to PCH. The approach includes detailed biochemical assays and cellular analysis to characterize the healthy functions of these proteins and how their dysfunction can result in disease. This research is crucial for developing potential therapeutic strategies for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatments for patients with pontocerebellar hypoplasia.
How similar studies have gone: While the specific focus on these proteins in relation to PCH is novel, similar research on RNA processing and its implications in other neurological disorders has shown promising results.
Where this research is happening
-
University of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Hayne, Cassandra K — University of Chicago
- Study coordinator: Hayne, Cassandra K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.